US FDA Showed ‘Several’ Cards In CBD Bill Comments – CV Sciences’ Duffy MacKay

In itself, the proposed US Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2020 may be of little consequence. But the FDA’s October comments on the bill were revealing, CV Sciences’ Duffy MacKay says.

More from United States

More from North America